BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6281750)

  • 1. The therapeutic effect of concurrent administration of 5-fluorouracil and allylestrenol or hexestrol in small doses on prostatic carcinoma.
    Takeuchi H
    Prostate Suppl; 1981; 1():111-7. PubMed ID: 6281750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of 5-fluorouracil combined with hormones in low dose as a basal treatment for prostatic carcinoma].
    Takeuchi H
    Hinyokika Kiyo; 1984 Nov; 30(11):1703-9. PubMed ID: 6099050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effects of allylestrenol on prostatic hypertrophy].
    Kohri K; Kurita T; Iguchi M; Kataoka K
    Hinyokika Kiyo; 1986 Mar; 32(3):486-92. PubMed ID: 2425611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of turinal in the combined treatment of threatened abortion and its effect on placental hormone function].
    Kosheleva NG; Svechnikova FA; Golumb SB
    Akush Ginekol (Mosk); 1981 May; (5):23-5. PubMed ID: 7306358
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study of allylestrenol (Perselin) on patients with prostatic hypertrophy].
    Fukuoka H; Ishibashi Y; Shiba T; Tuchiya F; Sakanishi S
    Hinyokika Kiyo; 1993 Jul; 39(7):679-83. PubMed ID: 7689782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effects of allylestrenol on benign prostatic hypertrophy by double-blind method].
    Shida K; Koyanagi T; Kawakura K; Nishida T; Kumamoto Y; Orikasa S; Sato S; Takeda M; Yamanaka H; Shimazaki J
    Hinyokika Kiyo; 1986 Apr; 32(4):625-48. PubMed ID: 2426932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of turinal and progesterone combined with chorionic gonadotropin on cellular immunity during the treatment of threatened abortion in the first and second trimesters].
    Zhuchenko PG; Lisovskaia TV; Gordiĭchuk VD
    Akush Ginekol (Mosk); 1988 Dec; (12):24-7. PubMed ID: 3266544
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical effect of allylestrenol on benign prostatic hypertrophy].
    Tajima A; Aso Y; Ushiyama T; Hata M; Kambayashi T; Ohmi Y; Masuda H; Nakahara M; Kitagawa M; Suzuki A
    Hinyokika Kiyo; 1986 Mar; 32(3):477-85. PubMed ID: 2425610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human chorion scan of first trimester of pregnancy during administration of gestanon and syntolutan.
    Papierowski Z
    Ann Med Sect Pol Acad Sci; 1976; 21(1-2):91-2. PubMed ID: 952085
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fundamental and clinical study of the anti-prostatic effect of allylestrenol].
    Yamanaka H; Kosaku N; Makino T; Shida K
    Hinyokika Kiyo; 1983 Sep; 29(9):1133-45. PubMed ID: 6203385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of allylestrenol (Org AL-25) on patients with prostatic hypertrophy--transrectal ultrasonography and urodynamic examination].
    Ohyama M; Tanifuji T; Haraguchi C; Fujii N; Higaki Y; Yoshida H; Imamura K
    Hinyokika Kiyo; 1986 Apr; 32(4):649-59. PubMed ID: 2426933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
    Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
    Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer.
    Herr HW
    J Urol; 1982 Mar; 127(3):462-5. PubMed ID: 7062419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of allylestrenol on hpl serum levels in high-risk pregnancies (author's transl)].
    Spona J; Müller-Tyl E; Leodolter S
    Z Geburtshilfe Perinatol; 1976 Oct; 180(5):356-62. PubMed ID: 969796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiotherapy of prostatic carcinoma].
    Fuse H; Katayama T; Akimoto S; Shimazaki J
    Hinyokika Kiyo; 1991 Aug; 37(8):801-8. PubMed ID: 1659778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early combined hormonal and chemotherapy for metastatic carcinoma of prostate.
    Mukamel E; Nissenkorn I; Servadio C
    Urology; 1980 Sep; 16(3):257-60. PubMed ID: 7423702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies on serum lipids in the patients with tumor of the prostate gland. 2nd. Report. Changes of serum lipids and lipoprotein fractions during the treatment of estramustine phosphate disodium, hexestrol and diethylstilbestrol 4, 4-diphosphoric ester for the patients with prostatic cancer (author's transl)].
    Yoshida H; Shimada M
    Nihon Hinyokika Gakkai Zasshi; 1980 Jan; 71(1):59-69. PubMed ID: 6155501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: a prospective randomized pilot trial.
    Breul J; Jakse G; Forster G; Lampel A; Rohani A; Hartung R
    Eur Urol; 1997; 32(3):280-3. PubMed ID: 9358213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of allylestrenol on patients with benign prostatic hyperplasia (BPH) evaluated with criteria for treatment efficacy in BPH].
    Noguchi K; Takeda M; Hosaka M; Kubota Y
    Hinyokika Kiyo; 2002 May; 48(5):269-73. PubMed ID: 12094708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of interruption of therapy with allylestrenol in patients with benign prostatic hypertrophy.
    Noguchi K; Harada M; Masuda M; Takeda M; Kinoshita Y; Fukushima S; Miyai K; Fukuoka H; Hosaka M
    Int J Urol; 1998 Sep; 5(5):466-70. PubMed ID: 9781436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.